Abstract:Previously, we have reported that siRNA-mediated survivin inhibition could enhance in vitro chemo- or radiosensitivity of colorectal cancer (CRC) cells. The aim of this study was to investigate whether that small interfering RNA (siRNA) targeting survivin could enhance in vivo chemo- or radiosensitivity of colorectal cancer cells.pSilencer4.1-shRNA targeting survivin (pSilencer4.1-s) and pSilencer4.1-NC (negative control) vectors were previously constructed by us. Two colorectal cancer cell lines (LoVo or HCT-8) were collected and used for forming subcutaneous tumors in nude mice. Then, the tumors were intratumorally injected with pSilencer4.1-s or pSilencer4.1-NC vectors combined with chemotherapy (5-FU) or radiotherapy (6Gy). Firstly, the expression of survivin mRNA and protein in tumors treated with pSilencer4.1-s or pSilencer4.1-NC alone was detected by RT-PCR and Western blotting or immunohistochemistry assays. Next, the tumor volumes were recorded. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to detect apoptosis of tumor cells and the activity of caspase-3 was detected.The expression of survivin mRNA and protein in tumor tissues treated with pSilencer4.1-s was significantly downregulated (p < 0.05). The immunostaining of survivin protein was also significantly weaker in tumor tissues treated with pSilencer4.1-s. Moreover, the volumes of the nude mice treated with pSilencer4.1-s and chemo- or radiotherapy decreased markedly compared with those of the mock- or pSilencer4.1NC-treated control combined with chemo- or radiotherapy. The apoptosis of tumor tissue cells treated with pSilencer4.1-s and chemo- or radiotherapy could be significantly increased compared with the mock- or pSilencer4.1-NC-treated control combined with chemo- or radiotherapy (p < 0.05), which might be associated with the active Caspase-3 pathway.siRNA-mediated survivin inhibition could enhance in vivo chemo- or radiosensitivity of CRC cells. Accordingly, the survivin gene might be a potential target for the chemoradiotherapy of CRC.

Downregulation of Smc1a Inhibits Growth and Increases Apoptosis and Chemosensitivity of Colorectal Cancer Cells

Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer

SMC1 promotes proliferation and inhibits apoptosis through the NF‑κB signaling pathway in colorectal cancer.

Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.

SMC1A knockdown induces growth suppression of human lung adenocarcinoma cells through G1/S cell cycle phase arrest and apoptosis pathways in vitro.

Knocking Down SMC1A Inhibits Growth and Leads to G2/M Arrest in Human Glioma Cells.

[Silencing of Adrm1 by RNA Interference Suppresses Proliferation of Colorectal Cancer Cells].

SLC38A1 Promotes Proliferation and Migration of Human Colorectal Cancer Cells

Zic1 Is Downregulated Through Promoter Hypermethylation, And Functions As A Tumor Suppressor Gene In Colorectal Cancer

Knockdown of the Novel Proteasome Subunit Adrm1 Located on the 20q13 Amplicon Inhibits Colorectal Cancer Cell Migration, Survival and Tumorigenicity.

SMC1A Promotes Growth and Migration of Prostate Cancer in Vitro and in Vivo

Low Expression of Smurf1 Enhances the Chemosensitivity of Human Colorectal Cancer to Gemcitabine and Cisplatin in Patient-Derived Xenograft Models

Structural maintenance of chromosomes 4 is a predictor of survival and a novel therapeutic target in colorectal cancer.

Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development

P53 Deficiency-Induced Smad1 Upregulation Suppresses Tumorigenesis and Causes Chemoresistance in Colorectal Cancers.

MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling

Identification of SMARCA1 as a key regulator for Colorectal Cancer

The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer

Knockdown of SLC39A7 Inhibits Cell Growth and Induces Apoptosis in Human Colorectal Cancer Cells

SiRNA-mediated Survivin Inhibition Enhances Chemo- or Radiosensivity of Colorectal Cancer Cells in Tumor-Bearing Nude Mice.

Effect of targeted mammalian sterile 20-like kinase 1 regulation on proliferation and apoptosis of SW480 colorectal cancer cells